Implantable insulin pump aids in delivering insulin into the peritoneal cavity and remains inside the body all the time. In addition, the insulin pump implanted in the peritoneal cavity helps in efficient absorption of insulin. The advent of implantable insulin pumps is anticipated to revolutionize the treatment of Type 1 diabetes and will also help find a constructive solution for truly effective artificial pancreas.
Implantable insulin pumps are still considered to be new and can offer better treatment solutions for people who suffer from diabetes. The major factors that fuel the growth of the market are rise in the population that suffers from diabetes along with increasing awareness about insulin treatment that is available in the market. In addition, technological advancements in implantable insulin pumps supplement the market growth.
In 2019, the market size of Implantable Insulin Pump is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Implantable Insulin Pump.
This report studies the global market size of Implantable Insulin Pump, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Implantable Insulin Pump production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Medtronic
Insulet Corporation
F. Hoffmann La Roche Ltd
Animas corporation
SOOIL Developments Co., Ltd
Johnson & Johnson
Tandem Diabetes Care, Inc
Aetna Inc
Market Segment by Product Type
Closed-Loop Insulin Pump
Open-Loop Insulin Pump
Market Segment by Application
Hospitals
Individuals (Self-Medication)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Implantable Insulin Pump status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Implantable Insulin Pump manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Implantable Insulin Pump are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Implantable Insulin Pump. Industry analysis & Market Report on Implantable Insulin Pump is a syndicated market report, published as Global (United States, European Union and China) Implantable Insulin Pump Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Implantable Insulin Pump market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.